Singapore invests $100 mn in Indian medical group

One of Singapore's two investment funds said Thursday it had paid $100 million for a minority stake in an Indian medical group, as part of its plan to shifts focus to emerging markets.

The Government of Singapore Corporation (GIC) did not mention the size of the shareholding in Chennai-based Vasan, an eye-care and dental-care specialist, but said the investment reflected the importance it attaches to India.

"The completion of this transaction also underscores our commitment to increase our investments in India," GIC's global head of direct investments Ang Eng Seng in a statement.

The fund in May 2010 bought a 6.58 percent stake in India's Fortis Healthcare, a private hospital chain.

Vasan's chairman and managing director A.M. Arun said the move would boost the company's growth prospects.

According to business consultancy Frost and Sullivan, Vasan was the world's largest eye-care provider with the highest number of stand-alone surgical centres in 2011.

GIC's latest investment is in line with its stipulated shift in focus to emerging markets amid uncertainly over the recovery of the US and European economies. The move was announced in July 2011.

According to GIC's 2010/2011 annual report, investments in Asia accounted for 27 percent of the fund's portfolio as of March 2011, up from 24 percent a year earlier.

GIC says on its website that it manages a portfolio worth over $100 billion ranging from equities to real estate and natural resources in more than 40 countries. Singapore's other sovereign wealth fund is Temasek Holdings.

add to favorites email to friend print save as pdf

Related Stories

Vodafone buys out Essar from India unit for $5 bn

Jul 02, 2011

British mobile phone giant Vodafone is taking full control of its Indian joint venture by buying out its local partner Essar Group, a statement said Saturday, ending a troubled relationship.

Is Singtel hanging up on India?

Jan 26, 2006

The India telecom sector was abuzz with reports that Singtel may be selling out of India ever since October when Vodafone acquired a smallish stake in Bharti Tele-Ventures for a huge $1.5 billion. But if the latest moves ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

10 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

13 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...